Stay updated on CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded related topic links: Rheumatoid arthritis and MedlinePlus Genetics to the page.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe related topics section for Rheumatoid arthritis and MedlinePlus Genetics has been removed. This change affects navigation but not the core study information on the page.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page now displays a new revision banner: Revision: v3.4.2. The old notice about government funding and operating status has been removed from the page.SummaryDifference0.5%

- Check41 days agoChange DetectedA general site notice about government funding and operating status was added, along with links to 'Rheumatoid arthritis' and related topics like 'MedlinePlus Genetics', and the revision changed from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check48 days agoChange DetectedGlossary toggle is now visible and a QC-related update label (Last Update Submitted that Met QC Criteria) plus Revision: v3.4.0 are added; several related topics, capitalization, and labels (e.g., No FEAR Act data) are updated or removed.SummaryDifference0.5%

Stay in the know with updates to CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page.